secwatch.observer — SEC 8-K summary
======================================

Issuer:     Decoy Therapeutics Inc. (DCOY)
CIK:        0001615219
Form:       8-K
Filed at:   2024-12-13T23:59:59+00:00
Accession:  0001615219-24-000092
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Salarius enters $10M equity purchase agreement with C/M Capital Fund
--------------------------------------------------------------------

- Up to $10M of common stock may be sold over 36 months at 95% of VWAP or closing price.
- Purchaser C/M Capital Master Fund obligated to buy when Company directs, subject to conditions.
- Exchange Cap of 19.99% of outstanding shares unless stockholder approval or 'at market' exception.
- Company to file registration statement within 30 days covering resale of shares.
- Proceeds for working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1615219/000161521924000092/0001615219-24-000092-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1615219/000161521924000092/flks-20241212.htm
  HTML page:      https://secwatch.observer/filing/0001615219-24-000092

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer